The Evolution of HTA in Emerging Markets Health-Care ... - TREE

More documents

Recommendations

Info

OHE Consulting Report for PhRMA 5 January 2011 Hsieh, C-‐R. and Sloan, F. (2008) Adoption of pharmaceutical innovation and the growth of drug expenditures in Taiwan: Is it cost-‐effective? Value in Health. 11(2), 334-‐344. Hughes, V (2008) China takes first steps toward healthcare and drug reforms. Nature Medicine. 14(11), 1132. IBGE. (Brazilian Institute of Geography and Statistics). (nd) Projection for year 2010. Available at www.ibge.gov.br. IFPMA. (no date) Health technology assessment and the value of medicines. IFPMA Position Statement. Geneva: International Association of Pharmaceutical Manufacturers and Associations. Institute of Medicine. (2009) Initial national priorities for comparative effectiveness research. Washington, DC: National Academies Press. Jakubowski, E. and Busse, R. (2001) What is “best practice” in health care? State of the art and perspectives in improving the effectiveness and efficiency of the European health care systems. Health Policy. 56, 235-‐250. Jirawattanapisal, T., Kingkaew, P., Lee, T-‐J. and Yang, M-‐C. (2009) Evidence-‐based decision-‐making in Asia-‐Pacific with rapidly changing health-‐care systems: Thailand, South Korea and Taiwan. Value in Health. 12(Suppl.3), S4-‐S11. Jurberg, C. (2008) Flawed but fair: Brazil’s health system reaches out to the poor. Bulletin of World Health Organization. 86(4), 248-‐249. Kutzin, J. (2001) A descriptive framework for country-‐level analysis of health care financing arrangements. Health Policy. 56, 171-‐204. Lancet. (2008) Health-‐system reform in China. The Lancet. 372(9648), 1437. In Lee, S-‐Y., Chun, C-‐B., Lee, Y-‐G and Seo, NK. That (2008) The national health insurance as one type of new typology: The case of South Korea and Taiwan. Health Policy. 85, 105-‐113. Lee, Y.C., Huang, K.H. and Huang, Y.T. (2007) Adverse pharmaceutical payment incentives and providers' behaviour: The emergence of GP-‐owned gateway pharmacies in Taiwan. Health Policy and Planning. 22(6), 427-‐ 435. Liu, G., Fukuda, T., Lee, C.E., Chen, V., Zheng, Q. and Kamae, I. D2009) Evidence-‐based decision-making in China, Japan and Singapore. Value in Health. 12(Suppl.3), S12-‐S17. Liu, Y.M., Yang, Y.H. and Hsieh, CR. (2009) Financial incentives and physicians' prescription decisions on the choice between brand-‐name and generic drugs: Evidence from Taiwan. Journal of Health Economics. 28(2), 341-‐349 Lu, J.F. and Hsiao, W.C. (2003) Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Affairs (Millwood). 22(3), 77-‐88. 116
OHE Consulting Report for PhRMA 5 January 2011 Mossialos, E., Dixon, A., Figueras, J. Kutzin, J. (2002) Funding health care: Options for Europe. European Observatory on Health Care Systems. Policy Brief No. 4. Copenhagen: World Health Organization Regional Office for Europe. Murray, J.L.C. and Frenk, J. (2000) A framework for assessing the performance of health systems. Bulletin of the World Health Organization. 78(6), 717-‐731. China MOH. (2003) National Health Services Survey. Neumann, P., Drummond, M, Jönsson, B., Luce, B., Schwartz, J. Siebert, U. and Sullivan, S. (2010) Are Key Principles for improved health technology assessment supported and used by HTA organisations? Journal of Health Technology Assessment in Health Care. 26(1), 71-‐78. Perleth, M.E., Jakubowski, E. and Busse, R. (2001) What is “best practice” in health care? State of the art and perspectives in improving the effectiveness and efficiency of the European health care systems. Health Policy. 56, 235-‐250. NICE. (2010) NICE signs memorandum of understanding with the Ministry of Health of China. Available online at http://www.nice.org.uk/aboutnice/niceinternational/NICESignsMemorandumOfUnderstandingWith ChineseMinistryOfHealth.jsp. OECD Health Data. (2010) Available online at http://www.oecd.org.uk. Pan-‐American Health Organization/World Health Organization. (2008) Health systems and services profile: Brazil. Monitoring and analysis of health systems change/reform. Washington, DC: PAHO. Available at www.lachealthsys.org. PhRMA. (nd) Health outcomes research: Principles for government supported health outcomes research and medical technologies and services. Washington, DC: Pharmaceutical Research and Manufacturers of America. Available at http://www.phrma.org/about/principles-‐guidelines/health-outcomes-‐research. PhRMA. (nd) Principles for use of evidence-‐based medicine: Advancing patient care and health care value. Washington, DC: Pharmaceutical Research and Manufacturers of America. PNAD. (2008) Pesquisa Nacional por Amostra de Domicílios. Available at www.ibge.org. Shih, S.F., Lew-‐Ting, C.Y., Chang, H.Y. and Kuo, K.N. (2008) Insurance covered and non-‐covered complementary and alternative medicine utilisation among adults in Taiwan. Social Science & Medicine. 67(7), 1183-‐ 1189. Shih, Y-‐C.T., Pan, I-‐W. and Tsai, Y-‐W. (2009) Information technology facilitates cost-‐effectiveness analysis in developing countries: An observational study of breast cancer chemotherapy in Taiwan. Pharmacoeconomics. 27(11), 947-‐961. 117
Page 1 and 2:
Consulting Report 1 The Evolution
Page 3 and 4:
OHE Consulting Report for PhRMA 5 J
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66: OHE Consulting Report for PhRMA 5 J
Page 115: OHE Consulting Report for PhRMA 5 J
Page 119: OHE Consulting Report for PhRMA 5 J
show all

The Evolution of HTA in Emerging Markets Health-Care ... - TREE

Create successful ePaper yourself

Delete template?

Save as template?